✦ LIBER ✦

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

✍ Scribed by Adamo, V; Lorusso, V; Rossello, R; Adamo, B; Ferraro, G; Lorusso, D; Condemi, G; Priolo, D; Di Lullo, L; Paglia, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin in combi

✍ Alessandra Fabi; Gianluigi Ferretti; Paola Papaldo; Nello Salesi; Mariangela Cic 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB

Non-pegylated liposomal doxorubicin comb

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Pegylated liposomal doxorubicin in combi

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB

Phase II study of liposomal doxorubicin

✍ D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Br 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

The clinical benefit of pegylated liposo

✍ Al-Batran, S-E; Bischoff, J; von Minckwitz, G; Atmaca, A; Kleeberg, U; Meuthen, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Gemcitabine and vinorelbine as second-li

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB